COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success -
COMMUNIQUÉ DE PRESSE
In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties
Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees -
COMMUNIQUÉ DE PRESSE
Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees -
COMMUNIQUÉ DE PRESSE
Newsmax to Attend the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference
Newsmax Inc. announces CEO Christopher Ruddy's attendance at RBC Capital Markets conference on Nov 18-19, 2025 for 1x1 meetings. Company overview and investor contacts provided -
-
COMMUNIQUÉ DE PRESSE
Augmentation de capital d’un volume augmenté de 70 millions de CHF achevée avec succès
Augmentation de capital de 70 millions de CHF réussie pour Fundamenta Real Estate SA, visant à financer des investissements immobiliers. Annonce événementielle conforme à l'art. 53 du règlement de cotation
